Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA topoisomerase I pseudogene 1 (TOP1P1) is a processed pseudogene derived from the active DNA topoisomerase I (TOP1) gene and localized to chromosome 1[3]. Unlike the functional TOP1 protein that regulates DNA topology during transcription, replication, and repair[1][7], TOP1P1 does not encode an active enzyme. It contains regions homologous to the C-terminal coding sequence of TOP1 and may be transcribed into antisense RNA, potentially influencing regulation of the parental gene, but its biological function remains uncertain[2][3]. There are no known direct links to disease roles, therapeutic drugs, or mechanisms of action for this pseudogene. Pseudogenes can show disease- and tissue-specific expression[5], and some pseudogene RNAs have been implicated in regulatory functions or as biomarkers in cancer, but such roles for DNA topoisomerase I pseudogene 1 have not yet been defined. The designation of TOP1P1 as a pseudogene means it is not considered a therapeutic target[2][3].
None; no drugs are known to act on TOP1P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA topoisomerase I pseudogene 1 (TOP1P1).